Literature DB >> 33556445

Neandertal introgression and accumulation of hypomorphic mutations in the neuropeptide S (NPS) system promote attenuated functionality.

Rainer K Reinscheid1, Fabrizio Mafessoni2, Annika Lüttjohann3, Kay Jüngling3, Hans-Christian Pape3, Stefan Schulz4.   

Abstract

The neuropeptide S (NPS) system plays an important role in fear and fear memory processing but has also been associated with allergic and inflammatory diseases. Genes for NPS and its receptor NPSR1 are found in all tetrapods. Compared to non-human primates, several non-synonymous single-nucleotide polymorphisms (SNPs) occur in both human genes that collectively result in functional attenuation, suggesting adaptive mechanisms in a human context. To investigate historic and geographic origins of these hypomorphic mutations and explore genetic signs of selection, we analyzed ancient genomes and worldwide genotype frequencies of four prototypic SNPs in the NPS system. Neandertal and Denisovan genomes contain exclusively ancestral alleles for NPSR1 while all derived alleles occur in ancient genomes of anatomically modern humans, indicating that they arose in modern Homo sapiens. Worldwide genotype frequencies for three hypomorphic NPSR1 SNPs show significant regional homogeneity but follow a gradient towards increasing derived allele frequencies that supports an out-of-Africa scenario. Increased density of high-frequency polymorphisms around the three NPSR1 loci suggests weak or possibly balancing selection. A hypomorphic mutation in the NPS precursor, however, was detected at high frequency in Eurasian Neandertal genomes and shows genetic signatures indicating that it was introgressed into the human gene pool, particularly in Southern Europe, by interbreeding with Neandertals. We discuss potential evolutionary scenarios including behavior and immune-based natural selection.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Archaic hominins; Human evolution; Neurotransmitter; Receptor; Selection

Mesh:

Substances:

Year:  2021        PMID: 33556445     DOI: 10.1016/j.peptides.2021.170506

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

Review 2.  Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep.

Authors:  Tetsuya Kushikata; Kazuyoshi Hirota; Junichi Saito; Daiki Takekawa
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-19

3.  Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance.

Authors:  Sion Park; Pia Flüthmann; Carla Wolany; Lena Goedecke; Hannah Maleen Spenner; Thomas Budde; Hans-Christian Pape; Kay Jüngling
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

4.  Effect of Neuropeptide S Administration on Ultrasonic Vocalizations and Behaviour in Rats with Low vs. High Exploratory Activity.

Authors:  Kadri Kõiv; Denis Matrov; Trine Uusen; Jaanus Harro
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.